A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use
Top Cited Papers
- 1 March 2005
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 26 (3) , 273-280
Abstract
Background and Objective: Fluoroquinolones have not been frequently implicated as a cause ofClostridium difficileoutbreaks. NosocomialC. difficileinfections increased from 2.7 to 6.8 cases per 1,000 discharges (P< .001). During the first 2 years of the outbreak, there were 253 nosocomialC. difficileinfections; of these, 26 resulted in colectomy and 18 resulted in death. We conducted an investigation of a largeC. difficileoutbreak in our hospital to identify risk factors and characterize the outbreak.Methods: A retrospective case-control study of case-patients withC. difficileinfection from January 2000 through April 2001 and control-patients matched by date of hospital admission, type of medical service, and length of stay; an analysis of inpatient antibiotic use; and antibiotic susceptibility testing and molecular subtyping of isolates were performed.Results: On logistic regression analysis, clindamycin (odds ratio [OR], 4.8; 95% confidence interval [CI95], 1.9-12.0), ceftriaxone (OR, 5.4; CI95, 1.8-15.8), and levofloxacin (OR, 2.0; CI95, 1.2-3.3) were independently associated with infection. The etiologic fractions for these three agents were 10.0%, 6.7%, and 30.8%, respectively. Fluoroquinolone use increased before the onset of the outbreak (P< .001); 59% of case-patients and 41% of control-patients had received this antibiotic class. The outbreak was polyclonal, although 52% of isolates belonged to two highly related molecular subtypes.Conclusions: Exposure to levofloxacin was an independent risk factor forC. difficile-associateddiarrhea and appeared to contribute substantially to the outbreak. Restricted use of levofloxacin and the other implicated antibiotics may be required to control the outbreak.Keywords
This publication has 43 references indexed in Scilit:
- Clindamycin, Cephalosporins, Fluoroquinolones, andClostridium difficile–Associated Diarrhea: This Is an Antimicrobial Resistance ProblemClinical Infectious Diseases, 2004
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999
- Ciprofloxacin and pseudomembranous colitisThe Lancet, 1990
- Ciprofloxacin and Clostridium difficile infectionThe Lancet, 1990
- Pseudomembranous colitis associated with ciprofloxacinThe Lancet, 1990
- Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody-positive patientJournal of Infection, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Antimicrobial Agents Implicated in Clostridium difficile Toxin-associated Diarrhea or ColitisObstetrical & Gynecological Survey, 1982
- Diarrhea Associated with Clindamycin and Ampicillin Therapy: Preliminary Results of a Cooperative StudyThe Journal of Infectious Diseases, 1977
- Ampicillin-associated diarrhea?A prospective studyDigestive Diseases and Sciences, 1975